| Antibody evasion by SARS-CoV-2 Omicron subvariants BA. 2.12. 1, BA. 4 and BA. 5 Q Wang, Y Guo, S Iketani, MS Nair, Z Li, H Mohri, M Wang, J Yu, ... Nature 608 (7923), 603-608, 2022 | 659 | 2022 |
| Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants Q Wang, S Iketani, Z Li, L Liu, Y Guo, Y Huang, AD Bowen, M Liu, ... Cell 186 (2), 279-286. e8, 2023 | 541 | 2023 |
| Antibody response to omicron BA. 4–BA. 5 bivalent booster Q Wang, A Bowen, R Valdez, C Gherasim, A Gordon, L Liu, DD Ho New England Journal of Medicine 388 (6), 567-569, 2023 | 169* | 2023 |
| Increasing disparities between resource inputs and outcomes, as measured by certain health deliverables, in biomedical research A Bowen, A Casadevall Proceedings of the National Academy of Sciences 112 (36), 11335-11340, 2015 | 146 | 2015 |
| Ig constant region effects on variable region structure and function A Janda, A Bowen, NS Greenspan, A Casadevall Frontiers in microbiology 7, 22, 2016 | 139 | 2016 |
| NIH peer review percentile scores are poorly predictive of grant productivity FC Fang, A Bowen, A Casadevall Elife 5, e13323, 2016 | 111 | 2016 |
| A monoclonal antibody to Cryptococcus neoformans glucuronoxylomannan manifests hydrolytic activity for both peptides and polysaccharides A Bowen, MP Wear, RJB Cordero, S Oscarson, A Casadevall Journal of Biological Chemistry 292 (2), 417-434, 2017 | 42 | 2017 |
| Transfusing convalescent plasma as post-exposure prophylaxis against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a double-blinded, phase 2 … S Shoham, EM Bloch, A Casadevall, D Hanley, B Lau, K Gebo, E Cachay, ... Clinical infectious diseases 76 (3), e477-e486, 2023 | 35* | 2023 |
| A synthetic glycan array containing Cryptococcus neoformans glucuronoxylomannan capsular polysaccharide fragments allows the mapping of protective epitopes L Guazzelli, CJ Crawford, R Ulc, A Bowen, O McCabe, AJ Jedlicka, ... Chemical Science 11 (34), 9209-9217, 2020 | 32 | 2020 |
| SARS-CoV-2 neutralising antibodies after bivalent versus monovalent booster Q Wang, A Bowen, AR Tam, R Valdez, E Stoneman, IA Mellis, A Gordon, ... The Lancet Infectious Diseases 23 (5), 527-528, 2023 | 31 | 2023 |
| XBB. 1.5 monovalent mRNA vaccine booster elicits robust neutralizing antibodies against XBB subvariants and JN. 1 Q Wang, Y Guo, A Bowen, IA Mellis, R Valdez, C Gherasim, A Gordon, ... Cell Host & Microbe, 2024 | 30 | 2024 |
| Structure-function analysis and therapeutic efficacy of antibodies to fungal melanin for melanoma radioimmunotherapy JD Nosanchuk, A Jeyakumar, A Ray, E Revskaya, Z Jiang, RA Bryan, ... Scientific reports 8 (1), 5466, 2018 | 24 | 2018 |
| Antibody-mediated catalysis in infection and immunity A Bowen, M Wear, A Casadevall Infection and immunity 85 (9), 10.1128/iai. 00202-17, 2017 | 24 | 2017 |
| Exploring Cryptococcus neoformans capsule structure and assembly with a hydroxylamine-armed fluorescent probe CJ Crawford, RJB Cordero, L Guazzelli, MP Wear, A Bowen, S Oscarson, ... Journal of Biological Chemistry 295 (13), 4327-4340, 2020 | 21 | 2020 |
| Revisiting the immunoglobulin intramolecular signaling hypothesis A Bowen, A Casadevall Trends in immunology 37 (11), 721-723, 2016 | 17 | 2016 |
| Variable region identical IgA and IgE to Cryptococcus neoformans capsular polysaccharide manifest specificity differences A Janda, E Eryilmaz, A Nakouzi, MA Pohl, A Bowen, A Casadevall Journal of Biological Chemistry 290 (19), 12090-12100, 2015 | 16 | 2015 |
| Cryptococcus neoformans capsule regrowth experiments reveal dynamics of enlargement and architecture MP Wear, E Jacobs, S Wang, SA McConnell, A Bowen, C Strother, ... Journal of Biological Chemistry 298 (4), 2022 | 9 | 2022 |
| The role of the constant region in antibody-antigen interactions: Redefining the modular model of immunoglobulin structure A Bowen, A Casadevall Structural Biology in Immunology, 145-170, 2018 | 5 | 2018 |
| SARS-CoV-2 neutralising antibodies after a second BA. 5 bivalent booster Q Wang, A Bowen, J Ho, RM Zhang, R Valdez, E Stoneman, A Gordon, ... The Lancet 402 (10415), 1827-1828, 2023 | 4 | 2023 |
| Reduction in Risk of Death Among Patients Admitted With COVID-19 Between the First and Second Epidemic Waves in New York City A Bowen, J Zucker, Y Shen, S Huang, Q Yan, MK Annavajhala, ... Open forum infectious diseases 9 (9), ofac436, 2022 | 3 | 2022 |
Lihong LiuColumbia UinversityVerified email at cumc.columbia.edu
